This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1992 May 14;326(20):1350-2.

doi: 10.1056/NEJM199205143262008.

The p53 tumor-suppressor gene

PMID: 1565147
DOI: 10.1056/NEJM199205143262008

Editorial

The p53 tumor-suppressor gene

A J Levine. N Engl J Med. 1992.

. 1992 May 14;326(20):1350-2.

doi: 10.1056/NEJM199205143262008.

Author

PMID: 1565147
DOI: 10.1056/NEJM199205143262008

No abstract available

PubMed Disclaimer

Comment on

Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma.
Toguchida J, Yamaguchi T, Dayton SH, Beauchamp RL, Herrera GE, Ishizaki K, Yamamuro T, Meyers PA, Little JB, Sasaki MS, et al. Toguchida J, et al. N Engl J Med. 1992 May 14;326(20):1301-8. doi: 10.1056/NEJM199205143262001. N Engl J Med. 1992. PMID: 1565143
Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms.
Malkin D, Jolly KW, Barbier N, Look AT, Friend SH, Gebhardt MC, Andersen TI, Børresen AL, Li FP, Garber J, et al. Malkin D, et al. N Engl J Med. 1992 May 14;326(20):1309-15. doi: 10.1056/NEJM199205143262002. N Engl J Med. 1992. PMID: 1565144

Similar articles

The p53 tumour suppressor gene.
Levine AJ, Momand J, Finlay CA. Levine AJ, et al. Nature. 1991 Jun 6;351(6326):453-6. doi: 10.1038/351453a0. Nature. 1991. PMID: 2046748 Review.
Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma.
Toguchida J, Yamaguchi T, Dayton SH, Beauchamp RL, Herrera GE, Ishizaki K, Yamamuro T, Meyers PA, Little JB, Sasaki MS, et al. Toguchida J, et al. N Engl J Med. 1992 May 14;326(20):1301-8. doi: 10.1056/NEJM199205143262001. N Engl J Med. 1992. PMID: 1565143
[Hereditary mutations in the p53 tumor suppressor gene; significance for clinical practice. National Work Group Hereditary Mamma Carcinoma].
Menko FH, Nooy MA, Vasen HF. Menko FH, et al. Ned Tijdschr Geneeskd. 1996 Jun 29;140(26):1347-50. Ned Tijdschr Geneeskd. 1996. PMID: 8710022 Review. Dutch. No abstract available.
Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms.
Malkin D, Jolly KW, Barbier N, Look AT, Friend SH, Gebhardt MC, Andersen TI, Børresen AL, Li FP, Garber J, et al. Malkin D, et al. N Engl J Med. 1992 May 14;326(20):1309-15. doi: 10.1056/NEJM199205143262002. N Engl J Med. 1992. PMID: 1565144
[What is the value of recent molecular biology knowledge for surgical oncologic therapy of soft tissue sarcoma?].
Willeke F. Willeke F. Langenbecks Arch Chir Suppl Kongressbd. 1998;115:393-8. Langenbecks Arch Chir Suppl Kongressbd. 1998. PMID: 9931648 Review. German.

See all similar articles

Cited by

Analysis of the p53 gene by PCR-SSCP in ten cases of Wilms' tumor.
Defavery R, Lemos JA, Kashima S, Bernardes JE, Scridelli CA, Covas DT, Tone LG. Defavery R, et al. Sao Paulo Med J. 2000 Mar 2;118(2):49-52. doi: 10.1590/s1516-31802000000200005. Sao Paulo Med J. 2000. PMID: 10772697 Free PMC article.
Expression of genes related to apoptosis, cell cycle and signaling pathways are independent of TP53 status in urinary bladder cancer cells.
da Silva GN, Evangelista AF, Magalhães DA, Macedo C, Búfalo MC, Sakamoto-Hojo ET, Passos GA, Salvadori DM. da Silva GN, et al. Mol Biol Rep. 2011 Aug;38(6):4159-70. doi: 10.1007/s11033-010-0536-x. Epub 2010 Nov 30. Mol Biol Rep. 2011. PMID: 21116856
p53 protein expression in central nervous system tumors: an immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies.
Karamitopoulou E, Perentes E, Diamantis I. Karamitopoulou E, et al. Acta Neuropathol. 1993;85(6):611-6. doi: 10.1007/BF00334670. Acta Neuropathol. 1993. PMID: 8337939
p53 protein expression in nephroblastomas: a predictor of poor prognosis.
Govender D, Harilal P, Hadley GP, Chetty R. Govender D, et al. Br J Cancer. 1998;77(2):314-8. doi: 10.1038/bjc.1998.48. Br J Cancer. 1998. PMID: 9461003 Free PMC article.
p53 in liver pathologies-taking the good with the bad.
Charni M, Rivlin N, Molchadsky A, Aloni-Grinstein R, Rotter V. Charni M, et al. J Mol Med (Berl). 2014 Dec;92(12):1229-34. doi: 10.1007/s00109-014-1223-5. Epub 2014 Nov 19. J Mol Med (Berl). 2014. PMID: 25404244 Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal